Search
for
Sort by
Research 271–300 of 1000+
- CHRONIC TELOGEN EFFLUVIUM
- Physiological Regeneration of Skin Appendages and Implications for Regenerative Medicine
- Elevated Free Testosterone Levels in Women With Acne
- Hormonal Treatment Strategies Tailored to Non-Binary Transgender Individuals
- Sex differences in arterial hypertension
- Side effects of common acne treatments
- The Medical and Psychosocial Associations of Alopecia: Recognizing Hair Loss as More Than a Cosmetic Concern
- Acne in women
- Manifestation of Hyperandrogenism in the Continuous Light Exposure-Induced PCOS Rat Model
- Pharmacologic Modulation of Sebaceous Gland Activity: Mechanisms and Clinical Applications
- Oral Contraceptives and Cyproterone Acetate in Female Acne Treatment
- What does acne genetics teach us about disease pathogenesis?
- Gender-Affirming Hormone Therapy for Transgender Men
- Alterations in Hair Follicle Dynamics in Women
- Gender Differences in Response to COVID-19 Infection and Vaccination
- Androgen receptors are only present in mesenchyme-derived dermal papilla cells of red deer (Cervus elaphus) neck follicles when raised androgens induce a mane in the breeding season
- Contraception and the dermatologist
- Hair Loss and Hirsutism in the Elderly
- The pathophysiology of delayed ejaculation
- COVID-19 and andrology: Recommendations of the French-speaking society of andrology (Société d’Andrologie de langue Française SALF)
- A Holistic Approach to Antiaging as an Adjunct to Antiaging Procedures: A Review of the Literature
- Polycystic Ovarian Syndrome in Adolescents
- FOX FORDYCE DISEASE IN A PREPUBERTAL GIRL
- The expression of the gene <i>asebia</i> in the laboratory mouse: 3. Sebaceous glands
- Targets to treat androgen excess in polycystic ovary syndrome
- GEOGRAPHIC TONGUE IN TWO CHILDREN WITH NONPUSTULAR PSORIASIS
- Oligomenorrhoea in Exercising Women
- Madarosis, milphosis, eyelash trichomegaly, and dermatochalasis
- Hyperandrogenism in Adolescent Girls
- Association of estrogen receptor gene variants (ESR1 and ESR2) with polycystic ovary syndrome in Tunisia